Pharmacy

The product has a market size of approximately $ 2.4 billion for the twelve months ending September 2010 according to IMS and will be launched after June 1, 2011. Aurobindo now has a total of 134 ANDA approvals (103 final approvals and 31 tentative approvals) from USFDA.  ï»¿

Aurobindo  Pharma  Ltd has received a tentative Abbreviated   New  Drug Application approval for Venlafaxine  hydrochloride extended-release capsules 37.5 mg, 75 mg and 150 mg (ANDA No 200834) has received the final approval from the US Food & Drug Administration (USFDA).

Venlafaxine hydrochloride extended-release capsules

37.5 mg, 75 mg andl50 mg are the generic equivalent of Wyeth Pharmaceuticals Inc's Effexor®XR capsules 37.5 mg, 75 mg and 150 mg. Venlafaxine hydrochloride extended-release capsules are indicated for the treatment of major depressive disorder (MDD) and falls under the neurological therapeutic category.